Results 51 to 60 of about 10,606 (259)

Inflammatory and Hemolytic Responses of Microaxial Flow Pump Temporary Ventricular Assist Devices via Axillary Access in Cardiogenic Shock

Medicina
Background and Objectives: The use of temporary left ventricular assist devices (tLVADs) for patients suffering from cardiogenic shock (CS) is becoming more common.
Leonie Schmack, Sadeq Ali-Hasan-Al-Saegh, Alexander Weymann, Nikolaus Pizanis, Payam Akhyari, Alina Zubarevich, Jasmin Sarah Hanke, Aron-Frederik Popov, Arjang Ruhparwar, Tienush Rassaf, Markus Kamler, Peter Luedike, Bastian Schmack   +12 more
doaj   +1 more source

Association between Impella device support and elevated rates of gout flares: a retrospective propensity-matched study

BMC Rheumatology
Background Impella is an advanced ventricular assist device frequently used as a bridge to heart transplantation. The association of Impella with increased rates of gout flares has not been studied.
Jorge Sinclair De Frías, Shahin Isha, Lorenzo Olivero, Lekhya Raavi, Sai Abhishek Narra, Smit Paghdar, Sadhana Jonna, Parthkumar Satashia, Rachel Hannon, Jessica Blasavage, Layton White, Titilope Olanipekun, Pankaj Bansal, Sean Kiley, Juan Carlos Leoni, Jose Nativí, Melissa Lyle, Mathew Thomas, Basar Sareyyupoglu, Si Pham, Michael Smith, Pablo Moreno Franco, Parag Patel, Devang Sanghavi   +23 more
doaj   +1 more source

Enhanced Hemocompatibility via Bivalirudin and Bicarbonate as Alternative to Heparin in a Catheter‐Based Axial‐Flow System

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Cardiovascular therapeutic devices typically require systemic heparin due to underlying thrombotic risk. The Impella axial flow system further relies on internal perfusion with either a heparin‐containing or sodium bicarbonate purge solution during operation.
Kaitlyn R. Ammann, Christine E. Outridge, Tiana Silver, Sami Muslmani, Jun Ding, Vladimir Gilman, Scott Corbett, Marvin J. Slepian   +7 more
wiley   +1 more source

Trends in Veno‐Arterial Extracorporeal Life Support With and Without an Impella or Intra‐Aortic Balloon Pump for Cardiogenic Shock

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Mechanical circulatory support devices, such as the intra‐aortic balloon pump (IABP) and Impella, are often used in patients on veno‐arterial extracorporeal life support (VA‐ECLS) with cardiogenic shock despite limited supporting clinical ...
Michael J. Hendrickson, Vardhmaan Jain, Kirtipal Bhatia, Christopher Chew, Sameer Arora, Joseph S. Rossi, Pedro Villablanca, Navin K. Kapur, Aditya A. Joshi, Arieh Fox, Kiran Mahmood, Edo Y. Birati, Mark J. Ricciardi, Arman Qamar   +13 more
doaj   +1 more source

Intravascular Lithotripsy for Calcific Coronary Bifurcations: Procedural Success and 1‐Year Clinical Outcomes

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Intravascular lithotripsy (IVL) has emerged as a promising treatment for heavily calcified coronary lesions. However, evidence regarding its effectiveness in calcific bifurcation lesions remains limited. Objective We aimed to evaluate the technical success and 1‐year clinical outcomes of IVL in calcified coronary bifurcation lesions.
Federico Oliveri, Giulia D'Acunto, Martijn. J.H. van Oort, Akshay Phagu, Ibtihal Al Amri, Brian O. Bingen, Valeria Paradies, Gianluca Mincione, Bimmer E. Claessen, Aukelien C. Dimitriu‐Leen, Joelle Kefer, Hany Girgis, Tessel Vossenberg, Frank Van der Kley, J. Wouter Jukema, Josè M. Montero‐Cabezas   +15 more
wiley   +1 more source

Impella Retrieval: Redux

JACC: Cardiovascular Interventions, 2017
We were pleased to read “First Experience With Successful Percutaneous Retrieval of Retained-Fractured Impella Device” in JACC: Cardiovascular Interventions [(1)][1]. Because temporary mechanical circulatory support devices are used with increasing frequency, we are likely to ...
openaire   +3 more sources

Extracorporeal membrane oxygenation and microaxial left ventricular assist device in cardiogenic shock: Choosing the right mechanical circulatory support to improve outcomesCentral MessagePerspective

JTCVS Open, 2023
Objective: To evaluate the outcomes of patients supported with Impella (CP/5.0) or venoarterial extracorporeal membrane oxygenation (VA-ECMO) for cardiogenic shock according to shock phenotype. The primary end point was 30-day survival.
Olina Dagher, MD, Pierre-Emmanuel Noly, MD, PhD, Walid Ben Ali, MD, PhD, Nadia Bouabdallaoui, MD, PhD, Lucian Geicu, MD, Roxanne Lamanna, Pavan Malhi, BScN, Elizabeth Romero, Anique Ducharme, MD, MSc, Philippe Demers, MD, MSc, Yoan Lamarche, MD, MSc   +10 more
doaj  

The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock

Journal of Cardiothoracic Surgery, 2020
Background Acute cardiogenic shock is associated with high mortality rates. The Impella device is a microaxial left ventricular assist device that can be inserted through the axillary artery.
Saeed Tarabichi, Hirohisa Ikegami, Mark J. Russo, Leonard Y. Lee, Anthony Lemaire   +4 more
doaj   +1 more source

Impella versus VA-ECMO for patients with cardiogenic shock: comprehensive systematic literature review and meta-analyses [PDF]

, 2023
Comprehensive systematic review of clinic and economic outcomes of studies on health technologies used in patients suffering from cardiogenic shock. Socio-economic outcomes including quality of life or resource use were not reported in any study.
Ardito, Vittoria, Pieri, Marina, Rognoni, Carla, Sarucanian, Lilit, Scandroglio, Anna Mara, Tarricone, Rosanna   +5 more
core   +1 more source

Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock‐CAT study

ESC Heart Failure, Volume 12, Issue 2, Page 1336-1345, April 2025.
Abstract Aims Mortality in cardiogenic shock (CS) remains elevated, with the potential for CS causes to impact prognosis and risk stratification. The aim was to investigate in‐hospital prognosis and mortality in CS patients according to aetiology. We also assessed the prognostic accuracy of CardShock and IABP‐SHOCK II scores.
Cosme García‐García, Teresa López‐Sobrino, Esther Sanz‐Girgas, Maria R. Cueto, Jaime Aboal, Pablo Pastor, Irene Buera, Alessandro Sionis, Rut Andrea, Judit Rodríguez‐López, Jose Carlos Sánchez‐Salado, Carlos Tomas, Jordi Bañeras, Albert Ariza, Josep Lupón, Antoni Bayés‐Genís, Ferran Rueda, Grup de Treball de Cures Agudes Cardiològiques Societat Catalana de Cardiologia   +17 more
wiley   +1 more source